US Stock MarketDetailed Quotes
SPRC SciSparc
- 0.2133
- -0.0004-0.19%
Close Dec 20 16:00 ET
- 0.2190
- +0.0057+2.67%
Post 20:01 ET
2.21MMarket Cap-0.04P/E (TTM)
0.2281High0.2014Low614.39KVolume0.2210Open0.2137Pre Close133.71KTurnover5.93%Turnover RatioLossP/E (Static)10.36MShares6.780052wk High0.29P/B2.21MFloat Cap0.201052wk Low--Dividend TTM10.36MShs Float221.0000Historical High--Div YieldTTM12.49%Amplitude0.0026Historical Low0.2170Avg Price1Lot Size
SciSparc Stock Forum
Sign in to post a comment
$SciSparc (SPRC.US)$ SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company
2 MINUTES AGO, 7:40 AM EST
VIA GLOBENEWSWIRE
According to the LOI, SciSparc's pharmaceuticals assets are valued at approximately US$11.6 million
TEL AVIV, Israel, Dec. 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapie...
2 MINUTES AGO, 7:40 AM EST
VIA GLOBENEWSWIRE
According to the LOI, SciSparc's pharmaceuticals assets are valued at approximately US$11.6 million
TEL AVIV, Israel, Dec. 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapie...
1
1
$SciSparc (SPRC.US)$
SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company
Monday, 16th December at 7:40 am
According to the LOI, SciSparc's pharmaceuticals assets are valued at approximately US$11.6 million
TEL AVIV, Israel, Dec. 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat di...
SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company
Monday, 16th December at 7:40 am
According to the LOI, SciSparc's pharmaceuticals assets are valued at approximately US$11.6 million
TEL AVIV, Israel, Dec. 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat di...
$SciSparc (SPRC.US)$
This is off the offcial nasdaq website. So who the fuck is lying. Also if this merger actually happend the price action hasnt reflected that at all. Also sci sparc is 72 million in debt. So how the hell are they able to give loans out to auto max. Smell like rotten fish , Hate to say it but i think this company is trying to steal the last bit of revenue from the people before it gets delisted next month if they cant keep the price above $1 for 10 consecutive days.
This is off the offcial nasdaq website. So who the fuck is lying. Also if this merger actually happend the price action hasnt reflected that at all. Also sci sparc is 72 million in debt. So how the hell are they able to give loans out to auto max. Smell like rotten fish , Hate to say it but i think this company is trying to steal the last bit of revenue from the people before it gets delisted next month if they cant keep the price above $1 for 10 consecutive days.
$SciSparc (SPRC.US)$ something seems fishy about this auto max merger. no price action at all and trading view isnt showing any news about it
3
$SciSparc (SPRC.US)$ On November 29, 2024, SciSparc announced the merger with AutoMax Motors, an Israeli vehicle distributor, to form a wholly-owned subsidiary. The merger agreement, initially signed on April 10, 2024, includes addendums from August 14 and November 26, 2024.
The merger will convert AutoMax's shares into SciSparc's ordinary shares. The estimated consideration is approximately $2.33 million, based on SciSparc's average share price of $0.237. The unaudited pro forma financial...
The merger will convert AutoMax's shares into SciSparc's ordinary shares. The estimated consideration is approximately $2.33 million, based on SciSparc's average share price of $0.237. The unaudited pro forma financial...
1
4
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$SciSparc (SPRC.US)$ SciSparc Ltd. has announced a second addendum to its merger agreement with AutoMax Motors Ltd., extending the deadline for the merger completion to March 31, 2025.
2
$SciSparc (SPRC.US)$ Reuters· 1 min ago
Scisparc Ltd: Entered Into Second Addendum to Merger Agreement With Automax Motors Ltd and Scisparc Merger Sub Ltd!
Right to terminate merger agreement if merger was not consummated by November 30, 2024, Was deferred to March 31, 2025!
Scisparc Ltd: Entered Into Second Addendum to Merger Agreement With Automax Motors Ltd and Scisparc Merger Sub Ltd!
Right to terminate merger agreement if merger was not consummated by November 30, 2024, Was deferred to March 31, 2025!
1
$SciSparc (SPRC.US)$ anybody got anything on the r/s ir if this merger is gonna happen. Dont all speak at once?
2
$SciSparc (SPRC.US)$ I think this is gonna bounce around between .24 to .26, possible dip .23. today
1
$SciSparc (SPRC.US)$ whats up? rescheduled meeting, not trading premarket before meeting…
2
No comment yet
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Paintr1 : So is this good or bad news?? The price reflects bad news. What the hell is this company doing. They are facing delisting next month